DNA strand breaks and hypoxia response inhibition mediate the radiosensitisation effect of nitric oxide donors on prostate cancer under varying oxygen conditions-Reference-Cited by-同舟云学术

DNA strand breaks and hypoxia response inhibition mediate the radiosensitisation effect of nitric oxide donors on prostate cancer under varying oxygen conditions

Published:2011-01 Issue:2 Volume:81 Page:203-210
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Stewart Grant D.,Nanda Jyoti,Katz Elad,Bowman Karen J.,Christie Jill G.,Brown D.J. Gordon,McLaren Duncan B.,Riddick Antony C.P.,Ross James A.,Jones George D.D.,Habib Fouad K.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference40 articles.

1. The relevance of a hypoxic tumour microenvironment in prostate cancer;Stewart;BJU Int,2010

2. Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study;Fiorucci;Gastroenterology,2003

3. Nitric oxide-induced apoptosis in tumor cells;Umansky;Adv Cancer Res,2001

4. NO-donating aspirin inhibits intestinal carcinogenesis in Min (APC(Min/+)) mice;Williams;Biochem Biophys Res Commun,2004

5. In vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines;Tesei;J Transl Med,2005

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spin-orbit charge transfer from guanine and 9-methylguanine radical cations to nitric oxide radicals and the induced triplet-to-singlet intersystem crossing;The Journal of Chemical Physics;2023-08-28

2. Targeting Transcription Factor YY1 for Cancer Treatment: Current Strategies and Future Directions;Cancers;2023-07-05

3. Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review);Molecular Medicine Reports;2022-05-25

4. Synergistic Therapy Using Doxorubicin-Loading and Nitric Oxide-Generating Hollow Prussian Blue Nanoparticles with Photoacoustic Imaging Potential Against Breast Cancer;International Journal of Nanomedicine;2021-08

5. Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer;BMC Urology;2021-07-01